141 - Peptide receptor radionuclide therapy for metastatic bronchopulmonary carcinoid tumours: A single ENETS Centre of Excellence experience (vol 127, pg S59, 2019)

被引：0

作者：

Evans, J. ^{[1
]}

Wang, W. M. ^{[1
]}

Newsom-Davis, T. ^{[2
]}

Sharma, R. ^{[1
]}

机构：

[1] Imperial Coll London, Surg & Canc, London, England

[2] Chelsea & Westminster Hosp, Med Oncol, London, England

来源：

LUNG CANCER | 2020年 / 145卷

关键词：

D O I：

10.1016/j.lungcan.2020.04.015

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：227 / 227

页数：1

共 10 条

[1] Peptide receptor radionuclide therapy for metastatic bronchopulmonary carcinoid tumours: a single ENETS Centre of Excellence experience
Evans, J.
Yang, W. M.
Newsom-Davis, T.
Sharma, R.
[J]. LUNG CANCER, 2019, 127 : S59 - S59
[2] An Australian multi-centre experience of the use of peptide receptor radionuclide therapy for bronchial carcinoid tumours
Lim, L. E.
Chan, D. L.
Thomas, D.
Wyld, D. K.
Cehic, G.
Macdonald, W.
Du, Y. T.
Tincknell, G.
Kuchel, A.
Pavlakis, N.
Bailey, D.
Davis, A.
Segelov, E.
[J]. ANNALS OF ONCOLOGY, 2019, 30 : 572 - 572
[3] Peptide Receptor Radionuclide Therapy In Broncopulmonary Neuroendocrine Tumours - Results Of A Single Centre Experience
Ferreira, G.
Castro, S.
Costa, C.
Violante, L.
Teixeira, J.
Duarte, H.
Sampaio, I. L.
[J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S89 - S89
[4] Characteristics of 252 patients with bronchopulmonary neuroendocrine tumours treated at the Copenhagen NET Centre of Excellence (vol 132, pg 141, 2019)
Grondahl, V.
Binderup, T.
Langer, S. W.
Petersen, R. H.
Nielsen, K.
Kjaer, A.
Federspiel, B.
Knigge, U.
[J]. LUNG CANCER, 2019, 135 : 235 - 235
[5] Clinical Efficacy in Treatment of Metastatic Gastrinoma and Glucagonoma with Peptide Receptor Radionuclide Therapy (PRRT) - A Single Centre Experience
Hung, T. J.
Michael, M.
Callahan, J.
Hicks, R.
Kong, G.
[J]. NEUROENDOCRINOLOGY, 2019, 108 : 213 - 213
[6] Single-centre experience with peptide receptor radionuclide therapy for neuroendocrine tumours (NETs): results using a theranostic molecular imaging-guided approach
S. Gordon
D. L. H. Chan
E. J. Bernard
M. E. Eslick
K. P. Willowson
P. J. Roach
A. F. Engel
R. Maher
S. J. Clarke
V. Agarwal
L. Yasmin
M. De Silva
S. Mascall
A. Conner
D. Nevell
N. Pavlakis
D. L. Bailey
[J]. Journal of Cancer Research and Clinical Oncology, 2023, 149 : 7717 - 7728
[7] Single-centre experience with peptide receptor radionuclide therapy for neuroendocrine tumours (NETs): results using a theranostic molecular imaging-guided approach
Gordon, S.
Chan, D. L. H.
Bernard, E. J.
Eslick, M. E.
Willowson, K. P.
Roach, P. J.
Engel, A. F.
Maher, R.
Clarke, S. J.
Agarwal, V.
Yasmin, L.
De Silva, M.
Mascall, S.
Conner, A.
Nevell, D.
Pavlakis, N.
Bailey, D. L.
[J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (10) : 7717 - 7728
[8] Single centre retrospective review of outcome of 177Lu-DOTATATE peptide receptor radionuclide therapy in the treatment of progressive metastatic neuroendocrine tumours: Survival, toxicity, and prognostic factors
Alsadik, Shahad
Gnanasegaran, Gopinath
Chen, Luohai
Quigley, Ann-Marie
Mandair, Dalvinder
Toumpanakis, Christos
Caplin, Martyn
Navalkissoor, Shaunak
[J]. JOURNAL OF NEUROENDOCRINOLOGY, 2022, 34 (11)
[9] MOLECULAR IMAGING PHENOTYPE AND EXQUISITE IMAGING AND HORMONAL RESPONSES OF ACTH-SECRETING METASTATIC NEUROENDOCRINE NEOPLASMS TO PEPTIDE RECEPTOR RADIONUCLIDE THERAPY (PRRT): A SINGLE CENTRE EXPERIENCE
Boehm, Emma
[J]. INTERNAL MEDICINE JOURNAL, 2023, 53 : 35 - 36
[10] Peptide receptor radionuclide therapy (PRRT) in European Neuroendocrine Tumour Society (ENETS) grade 3 (G3) neuroendocrine neoplasia (NEN) - a single-institution retrospective analysis (vol 45, pg 262, 2017)
Thang, Sue Ping
Lung, Mei Sim
Kong, Grace
Hofman, Michael S.
Callahan, Jason
Michael, Michael
Hicks, Rodney J.
[J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 (02) : 323 - 323

← 1 →